ARMS test for diagnosis of factor V(Leiden) mutation and allele frequencies in France

Molecular and Cellular Probes

Volumn 12, Issue 2, 1998, Pages 121-123

  Bathelier, C ^a   Champenois, T ^a   Lucotte, G ^b  

^a LCL   (France)

^b HÔPITAL MAISON BLANCHE   (France)

Author keywords

Activated protein C resistance; Amplification refractory mutation system; Factor V(Leiden) mutation; Frequency of the mutation in the normal population; Thrombophilic patients

Indexed keywords

BLOOD CLOTTING FACTOR 5; DNA; PRIMER DNA;

ALLELE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; EXON; FRANCE; GENE FREQUENCY; GENE MUTATION; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION MAPPING; THROMBOPHILIA;

EID: 0032052240     PISSN: 08908508     EISSN: None     Source Type: Journal    
DOI: 10.1006/mcpr.1997.0152     Document Type: Article

References (16)

1. 1. Dahlbäck, B., Carlsson, M. & Svensson, P. J. (1993). Familial thrombophilia due to a previously unrecognised mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proceedings of the National Academy of Sciences of the United States of America 90, 1004-8.
2. 2. Svensson, P. J. & Dahlbäck, B. (1994). Resistance to activated protein C as a basis for venous thrombosis. New England Journal of Medicine 330, 517-21.
3. 3. Bertina, R. M., Koeleman, B. P. C., Koster, T. et al. (1994). Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369, 64-7.
4. 4. Greengard, J. S., Sun, X., Xu, X. et al. (1994). Activated protein C resistance caused by Arg 506 Gln mutation in factor Va. Lancet 343, 1362-3.
5. 5. Voorberg, J., Roelse, J., Koopman, R. et al. (1994). Association of idiopathic thromboembolism with single point mutation at Arg 506 of factor V. Lancet 343, 1535-6.
6. 6. Newton, C. R., Graham, A., Hepinstall, L. E. et al. (1989). Analysis of any mutation in DNA: the amplification refractory mutation system. Nucleic Acids Research 17, 2503-9.
7. 7. Gripe, L. D., Moore, K. D. & Kane, W. H. (1992). Structure of the gene for human coagulation factor V. Biochemistry 31, 3777-85.
8. 8. Beauchamp, N. J., Daly, M. E., Hampton, K. K. et al. (1994). High prevalence of a mutation in the factor V gene within the UK population: relationship to activated protein C resistance and familial thrombosis. British Journal of Haematology 88, 219-22.
9. 9. Kirshbaum, N. E. & Foster, P. A. (1995). The polymerase chain reaction with sequence specific primers for the detection of the factor V mutation associated with activated protein C resistance. Thrombosis and Haemostasis 74, 874-8.
10. Leiden by allele-specific PCR amplification. Thrombosis and Haemostasis 75, 757-9.
11. Leiden from a drop of blood by PCR-SSCP. Thrombosis and Haemostasis 76, 735-7.
12. Leiden using heteroduplex technology. Thrombosis and Haemostasis 77, 119-22.
13. 13. Emmerich, J., Poirier, O., Evans, A. et al. (1995). Myocardial infection, Arg 506 to Gln factor V mutation, and activated protein C resistance. Lancet 345, 321.
14. Leiden (Arg 506 Gln) in France. British Journal of Haematology 99, 241.
15. Leiden. Lancet 346, 1133-4.
16. Leiden. British Journal of Haematology 95, 579-86.